362x Filetype DOCX File size 0.31 MB Source: namsa.com
SAMPLE SUBMISSION FORM
www.namsa.com
Instructions: Electronically complete a single form for each set or batch of samples submitted using Microsoft Word.
The form must be completed in its entirety to expedite the study initiation. Fields identified in bold must be completed before
your order can be processed. Fields marked with * may appear on your final report. Upon completion, please print, sign and date
the form at the bottom. Please include this form with your sample and ship to the NAMSA address that appears below. If you have
any questions, please reach your usual contact at NAMSA or a Technical Advisor at +33 478 079 234 for France and
+49 6022 50638 00 for Germany
Sponsor Information
Ship To (this address may be reported in the final report) Bill To ☐ Same as Ship To Information
Company Name Company Name
Contact Address
Address City, State, Zip
City, State, Zip Country
Country Phone (Accounts Payable)
Phone Details of the order
E-mail Purchase Order Number
Mobile Phone Proposal Number
Test Article Characterization
Definitions are available on our website: How to Address a Sample Submission Form / Guide de remplissage de la Fiche Information
Produit
*Name
*Reference
*Batch/Lot ID
Type If Other, please describe:
*Physical ☐ Illustrations or photos attached
Description If not available, please provide a detailed description for characterization and identification of the
test article (nature of material, shape of material, color, consistency, size, packaging, …):
Intended Clinical ☐ IFU attached
Use If IFU not available, please provide a detailed description :
☐ Sterile – ☐ Not Sterile ☐ Aseptically Prepared
*Sterility ☐ NAMSA to Sterilize (Steam – Additional fee will apply)
If Other, please describe:
Stability testing is the responsibility of the sponsor and is subject to authorities audit
*Stability Expiration date (Shelf life):
Stability after Does the stability of the test article change upon opening? ☐ No (Not applicable)
opening packaging ☐ Yes
If yes, for how many hours, days, months is the test article stable upon
opening:
*Raw materials Contact to Patient? Contact surface Part name?
(Name, CAS Number, Trade Name, % w/w) (direct, indirect or no area? (if applicable)
contact) (if applicable)
*Composition
Please complete the 4
sections or provide a separate
document with these
information in a tabular format
☐ Separate document attached
Shipping conditions Temperature sensitive ☐ No (uncontrolled conditions) ☐ Yes (please complete below)
Sponsor’s responsibility : Temperature: If Other, describe:
The Sponsor needs to establish Monitoring
the conditions the test item is If Other, describe:
expected to be subject to during system:
transportation (appropriate Refrigerant: If Other, describe:
vehicle, container …). Appropriate
monitoring measures or special Light sensitive ☐ No ☐ Yes Describe special care:
care is required if the test item is
temperature, light and/or Humidity sensitive ☐ No ☐ Yes Describe special care:
humidity sensitive. Other: Describe special care:
Title: Sample submission form ID: E-QUA183 Status: Release
Page 1 of 1 Revision: 7 Effective date: 30 Juil 2021
SAMPLE SUBMISSION FORM
www.namsa.com
Test article Reminder (will automatically be fulfilled before printing)
Name
Reference
Batch/Lot ID:
*Storage Conditions Protected from light ☐ No ☐ Yes Describe special care:
at NAMSA Protected from ☐ No ☐ Yes Describe special care:
Humidity
Other: Describe special care:
If liquid or gel Number (vials, syringes…): Quantity per mL
container:
Quantity of test If powder Number (vials, syringes…): Quantity per g
article (s) submitted container:
If solid Quantity (devices, Quantity per
packages…): packaging:
Test Article Preparation
If applicable, instruction before use to assure
If the test device is a gel, liquid, homogeneity:
cream or powder, please indicate: Osmolality: pH:
☐ Needles are provided
Need cleaning and/or disinfection ☐ No ☐ Yes,
before use? describe:
Need specific preparation or handling ☐ No ☐ Yes,
before use? describe:
Part (s) of the test article need to be ☐ No ☐ Yes, list:
excluded?
Can be Cut ☐ No ☐ Yes (cutting can expose inner surfaces – cutting will destroy the test
article)
Is an Absorbent? ☐ No ☐ Yes,
describe:
Is there any surface coating? ☐ No ☐ Yes,
describe:
Other Special Instructions
Is the test article tested in its final
product form and condition ☐ No ☐ Yes
(packaging)?
Test article Extraction
Includes multiple components with ☐ No ☐ Yes (If yes, is advised to choose the ratio below based on the
different thicknesses (> and < 0.5 thinnest material layer of that component)
mm)?
*Test Article Surface
2
*Extracts to be Prepared Area cm
by When needed, NAMSA might adapt the ratio (Total contact surface area)
*Test Article Weight g
*Extraction Conditions Cytotoxicity: Other Tests:
(the highest temperature that will If Other, please describe:
not degrade the test article is Other conditions to be justified. The extraction time If Other, please describe:
recommended) may be less than 24h but no less than 4h Other conditions to be justified
Other Information
Countries/Regions that test ☐ USA ☐ China ☐ Other:
data will be submitted to ☐ Europe ☐ Japan ☐ Not known
*Disposal
For test article to be Other: Account #:
returned Special handling instructions:
Mandatory for liquid, gel, powder, paste, cream and/or if the test article is a Pharmaceutical or Biologic
Safety Data
Title: Sample submission form ID: E-QUA183 Status: Release
Page 2 of 2 Revision: 7 Effective date: 30 Juil 2021
SAMPLE SUBMISSION FORM
www.namsa.com
Test article Reminder (will automatically be fulfilled before printing)
Name
Reference
Batch/Lot ID:
Nature of the test article's contact
Surface device
External communicating
device
Implant device
☐ Male ☐ Female
Population ☐ Adults ☐ Children ☐ Neonates
Minimum weight if specified:
Contact duration If < 4h, Please specify contact
duration:
If > 30 days
Clinical exposure per patientMaximum number of test article that could be used in a patient**:
Dose Based Threshold (DBT) µg/day
(For chemical analysis only)
** If more than one, please describe the exposure scenario (for example: “two devices will be implanted at the same time”; “a new device
will be implanted every three years”; “a patient may use the re-usable device daily, up to four treatments/day, 10 minutes/treatment”;
etc.)
Please print this form and sign. Signature must be handwritten.
By this signature, the Sponsor assures the exactitude of the information listed above.
Sponsor Function: Date:
Signature:
Title: Sample submission form ID: E-QUA183 Status: Release
Page 3 of 2 Revision: 7 Effective date: 30 Juil 2021
SAMPLE SUBMISSION FORM
www.namsa.com
Shipping Information
Please, include a signed copy of this form and ship to the facility as designated below. Thank you for your business.
Germany Facility: France Facility:
Chemical Analysis In Vitro Toxicology
Chemical Characterization In Vivo Toxicology
In Vivo Efficacy and Functional
Antimicrobial and Microbiology Specials
Microbiology (Bioburden, Sterility, LAL)
Histology
NAMSA Laboratory Services GmbH NAMSA
Attention: Samples reception Attention: Samples reception
Industrie Center Obernburg 115 Chemin de l’Islon
63784 Obernburg 38670 Chasse sur Rhône
Germany France
Documentation Required
Please, include these documents attached with this form.
Information for Use (IFU)
Illustrations or photos of the device
If applicable :
Safety Data
Title: Sample submission form ID: E-QUA183 Status: Release
Revision: 7 Effective date: 30 Juil 2021
no reviews yet
Please Login to review.